or
forgot password

    • cancer clinical trials in glendale, AZ

    • A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)
    Arizona Center for Hematology Oncology
    Glendale, Arizona 85306
    Metastatic Pancreatic Adenocarcinoma
    A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
    Arizona Center for Hematology Oncology
    Glendale, Arizona 85306
    Adenocarcinoma of the Lung
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Palo Verde Cancer Specialists
    Glendale, Arizona 85304
    Advanced Prostate Cancer, Prostatic Neoplasms
    A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
    Arizona Center for Cancer Care
    Glendale, Arizona 85306
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
    NBRST: Prospective Neo-adjuvant REGISTRY Trial
    Arizona Center for Cancer Care
    Glendale, Arizona 85306
    Breast Cancer
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Arizona Center for Cancer Care
    Glendale, Arizona 85306
    Colorectal Cancer
    Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies
    Arizona Center for Cancer Care
    Glendale, Arizona 85306
    Colorectal Cancer
    Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
    Clinical Trials of Arizona
    Glendale, Arizona 85306
    Prostate Cancer
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    Palo Verde Hematology & Oncology
    Glendale, Arizona 85304
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma
    Palo Verde Hematology Oncology
    Glendale, Arizona 85304
    Multiple Myeloma
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Palo Verde Hematology Oncology
    Glendale, Arizona 85304
    Non Small Cell Lung Carcinoma
    Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
    Palo Verde Hematology Oncology
    Glendale, Arizona 85304
    Stage II Multiple Myeloma, Stage III Multiple Myeloma, Refractory Plasma Cell Neoplasm
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Palo Verde Hematology/Oncology, Ltd.
    Glendale, Arizona 85204
    Lung Cancer, Non-small-cell Lung Carcinoma
    A Multiple Myeloma Trial in Patients With Bone Metastases
    Palo Verde Hematology Oncology
    Glendale, Arizona 85304
    Multiple Myeloma
    Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects
    Sun Valley Arthritis Center
    Glendale, Arizona 85308
    Arthritis, Rheumatoid, Arthritis, Psoriatic, Ankylosing Spondylitis
    A Phase III Trial For Patients With Metastatic Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician.
    Glendale, Arizona
    Breast Cancer, Breast Neoplasms, Cancer of the Breast
    Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.
    Palo Verde Hematology Oncology Ltd.
    Glendale, Arizona 85304
    Cancer Cachexia
    APF530 or Palonosetron Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
    Palo Verde Hematology Oncology - Glendale
    Glendale, Arizona 85304
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia
    Palo Verde Hematology Oncology, Ltd.
    Glendale, Arizona 85304
    Cancer Cachexia
    A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Palo Verde Hematology/Oncology, Ltd.
    Glendale, Arizona 85204
    Diffuse Large B-cell Lymphoma
    Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site 027

    Trial Locations
    BioSante Site 027
    BioSante Site 145
    Hypoactive Sexual Desire Disorder